Daniel Roncone, MD
Nephrology · Columbus, OHNPI 1457333684
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $243 of the $281 with a category attached, or 86.5%. 7 manufacturers reported payments, led by Aurinia Pharma U.S., Inc. at 43.5% of the total. That places this record below the midpoint for nephrology clinicians in OH, where the typical reported total is $965.
Across 18 payments — averaging $15.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aurinia Pharma U.S., Inc.$122
- Fresenius USA Marketing, Inc.$55
- Novo Nordisk$29
- Vifor Pharma, Inc.$24
- Travere Therapeutics, Inc.$23
- AMAG Pharmaceuticals, Inc.$15
- plus $13 from 1 others
What the payments were for
- Food & beverage$24386%
- Education$3814%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aurinia Pharma U.S., Inc. | 1 | $122 |
| Fresenius USA Marketing, Inc. | 2 | $55 |
| Novo Nordisk | 1 | $29 |
| Vifor Pharma, Inc. | 1 | $24 |
| Travere Therapeutics, Inc. | 11 | $23 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Amgen | 1 | $13 |
How this compares
$281 in reported general payments places this provider in the 20th percentile of 450 nephrology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuryxiaFerric Citrate | 14 | $32,044 |
| JardianceEmpagliflozin | 18 | $18,016 |
| Nifedipine ErNifedipine | 23 | $978 |
| Furosemide | 187 | $959 |
| Hydralazine Hcl | 35 | $897 |
| Losartan Potassium | 57 | $787 |
| Calcitriol | 25 | $559 |
| Carvedilol | 74 | $494 |
| Doxazosin Mesylate | 27 | $475 |
| Valsartan | 13 | $431 |
| Amlodipine Besylate | 95 | $364 |
| Potassium Chloride | 22 | $317 |
| Spironolactone | 31 | $279 |
| Allopurinol | 48 | $274 |
| Lisinopril | 49 | $214 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Columbus
- Brad RovinColumbus$379K
- Samir ParikhColumbus$145K
- Isabelle AyoubColumbus$116K
- Anil AgarwalColumbus$99K
- Karim AttiaColumbus$43K
- Rima KangColumbus$28K
- Salem AlmaaniColumbus$21K
- Todd PesaventoColumbus$20K
- Naveen SingriColumbus$11K
- Jessica GrecoColumbus$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.